Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Maximilian Thormann is a pioneering figure at the intersection of interventional oncology and medical robotics, with a focus on noninvasive cancer therapies and advanced human-machine interfaces. His most impactful work centers on histotripsy—a novel, non-thermal focused ultrasound technique that mechanically liquefies tumors without incisions. As the lead author of the #HOPE4LIVER pivotal trial (2025, 30 citations), Dr. Thormann provided the first robust 1-year clinical outcomes for hepatic histotripsy, demonstrating its safety and efficacy for both primary and metastatic liver tumors—a landmark achievement that positions this technology as a potential game-changer in oncology. Beyond clinical therapy, he has advanced the field of robotic ultrasound through the development of a multimodal, touchless user interface (2022, 13 citations), enabling sterile, intuitive control during procedures. His work on MRI-compatible, sensorless haptic feedback for cable-driven robots (2024) further extends his expertise into teleoperated needle-based interventions, enhancing surgical precision and safety. With a career defined by translating cutting-edge engineering into tangible clinical solutions, Dr. Thormann’s contributions are shaping the future of minimally invasive, image-guided medicine.